MAP 2.63% 18.5¢ microba life sciences limited

budapest!!, page-8

  1. 1,461 Posts.
    it depends on wha valuation model you use as to paying to much for an asset. Macquarie has a habit of using projected figures (and acurately) while most number crunchers will only use historical, and as a journalist who has to report you would say the futuristic thinkers seems to be over valuing an asset (by a factor of two) ... but when you bring a private asset into market cap its generally worth twice the amount
 
watchlist Created with Sketch. Add MAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.